N/A N=182 Use of Nudges To Enhance Enrollment in Critical Care Research
Critical Illness
Primary: Consent Rate — 27; 30 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=260 Re-usable Respimat® Soft MistTM Inhaler Study
Pulmonary Disease, Chronic Obstructive
Primary: Mean Total Patient Satisfaction and Preference Questionnaire (PASAPQ) Score — 84.26; 81.59; 83.24 Score on a scale
N/A N=100 Detection of Colonic Polyps Via a Large Scale Artificial Intelligence (AI) System
Colonic Polyp
Primary: Number of Additional Polyps Detected by the DEEP System in Real Time Colonoscopy — 0.89 Added polyps detected per colonoscopy
Early Phase 1 N=114 Pre-operative Analgesics for Postoperative Pain Relief After Dental Treatment
Pain, Postoperative · Analgesia
Primary: Postoperative Pain, as Measured by Wong-Baker Facial Rating Pain Scale ,After Routine Dental Treatment — 20; 20; 7; 11 Participants
N/A N=38 Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy
Schizophreniform Disorders
Primary: Change Over Time on the mDES - Positive — 0.35; 0.42; 0.62; 0.25 units on a scale
N/A N=176 Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView
Bronchoscopy · Anesthesia
Primary: User Preference of Scope — 103; 37; 35 Participants
Phase 3 N=5,451 Strategies to Reduce Injuries and Develop Confidence in Elders
Accidental Falls · Wounds and Injuries
Primary: First Adjudicated Serious Fall-Related Injury — 4.87; 5.34 events per 100 person years of follow-up — p=0.245
N/A N=1 Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab
Relapsing Polychondritis
Primary: Physician Global Assessment of Disease Activity — 21; 14; 12; 43 mm
Phase 2 N=29 Low Dose Naltrexone for Chronic Pain From Arthritis
Osteoarthritis · Arthritis, Rheumatoid · Arthritis, Psoriatic
Primary: Brief Pain Inventory - Pain Interference — -23; -22 units on a scale — p=0.90
Phase 2 N=186 A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Fibromyalgia
Primary: Change From Baseline to Week 8 in Mean Daily Average Pain Score Assessed by NRS — -1.26; -1.60 Units on a scale — p=0.086
N/A N=50 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI
Peripheral Artery Disease
Primary: Procedural Success: — 49 Participants
Phase 2 N=12 Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Discoid Lupus Erythematosus
Primary: Cutaneous LE Diseases Area and Severity Index (CLASI) Score Based on Extent of Symptoms
N/A N=209 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Defibrillator (ICD) Patients
Complication of Cardiac Defibrillator
Primary: Economic Impact of Remote Monitoring on Hospitals and Patients — 1044.89; 482.87 Euro (€) — p=<0.0001
Phase 4 N=122 Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant
Hepatitis C · Transplantation Disease Transmission
Primary: Proportion of Participants With HCV RNA Level Below Limits of Quantification (LOQ) — 23 Participants
Phase 1 N=24 A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)
ALS
Primary: Safety as Measured by the Number of Participants Experiencing Adverse Events — 16 Participants